Company page

Cosmo Pharmaceuticals Nv

Cosmo Pharmaceuticals NV, traded under the ticker COPN, is a public company based in Switzerland with a market capitalization of approximately 1.71 billion Swiss francs. The company focuses on developing innovative pharmaceutical products, particularly in the field of gastrointestinal health. Cosmo aims to address unmet medical needs through its research and development efforts.